USPTO serial 99806547
LABCORP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MOSCATI, JUSTIN RONALD
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with LABCORP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura C. Miller
Laura C. Miller KILPATRICK TOWNSEND & STOCKTON LLP1001 West Fourth StreetWinston-Salem, NC 27101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Clinical medical assays and reagents for medical diagnostic use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing liquid biopsy samples for medical diagnostic purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing liquid biopsy samples for medical diagnostic purposes; Medical diagnostic reagents and assays to test stool samples; Medical testing kits comprised of medical diagnostic reagents and assays for testing stool samples for medical purposes; Medical diagnostic assays for detecting the presence of antibodies for medical purposes; Diagnostic kits for medical use comprised of medical diagnostic reagents and assays for testing for the presence of antibodies; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; Medical diagnostic assays for pharmaceutical and medical use to detect the presence of neutralizing antibodies; Diagnostic preparations in the nature of companion compounds for medical use; companion diagnostic agents for medical use; Specimen collection kits for use in virus testing comprised primarily of medical diagnostic reagents and also including collection tubes, lancets, swabs, and collection envelopes for medical purposes; Specimen collection kits for use in genetic testing comprised primarily of medical diagnostic reagents | ACTIVE | — |
| 009 | Downloadable computer software for managing, collecting, tracking, and analyzing data in the fields of laboratory testing, diagnostic testing, and clinical trials; downloadable computer software for managing clinical trial operations, namely, software for tracking clinical trial participants, recording clinical trial data, monitoring clinical trial progress, and managing clinical trial protocols; downloadable computer software for collecting, processing, and analyzing medical and diagnostic information; downloadable computer software for monitoring clinical trial subjects and tracking subject compliance with clinical trial protocols; downloadable computer software for managing laboratory information, laboratory test results, and diagnostic testing data; downloadable computer software for tracking, storing, and analyzing medical information related to clinical trial participants and laboratory test results; downloadable computer software for providing information in the fields of laboratory testing, clinical testing, medical testing, diagnostic testing, and genetic testing | ACTIVE | — |
| 010 | Diagnostic test kits for medical use comprised of devices for collecting bodily fluid samples, namely, collection tubes, lancets, probes, and collection pouches for medical diagnostic testing purposes; Diagnostic test kits comprised of medical implements in the nature of stool collection tubes, swabs for medical use, collection envelopes, and containers for collecting patient stool samples for medical analysis; Genetic testing kits for medical purposes comprised of devices for collecting bodily fluid samples, namely, collection tubes, lancets, probes, collection envelopes, and swabs; DNA collection kits for medical purposes comprised of DNA collection swabs, protective medical specimen tubes, and integrated desiccants; Biosample specimen collection tubes, namely, collection tubes for blood or plasma samples; Medical diagnostic test kits for testing for drugs of abuse, comprised primarily of medical diagnostic test apparatus and also including chemical reagents; Diagnostic immunoassay test apparatus for medical use; Medical diagnostic apparatus for testing for drugs of abuse | ACTIVE | — |
| 042 | Scientific laboratory services; laboratory analysis and testing services for scientific research and product development; laboratory testing services in the fields of biotechnology, pharmaceuticals, biologics, vaccines, and medical products; laboratory testing and analysis services in connection with drug discovery, drug development, and pharmaceutical research; central laboratory services for clinical research studies and clinical trials; laboratory testing and analysis of biological, chemical, and molecular samples for research purposes; biomarker discovery, development, and testing services for scientific and research purposes; bioanalytical laboratory testing services; genomic, molecular, and proteomic analysis for scientific research purposes; genetic analysis and sequencing services for scientific research purposes; assay development, validation, and optimization services for research and drug development; pharmacogenomic and pharmacogenetic laboratory testing services for research purposes; laboratory services for analyzing blood, tissue, cellular, and other biological specimens for research purposes; microbiology, virology, immunology, hematology, and molecular biology laboratory research services; laboratory testing services for evaluating biomarkers, antibodies, hormones, pathogens, and molecular targets for scientific research; laboratory testing and analysis services for pharmaceutical quality control, formulation analysis, and chemistry, manufacturing, and controls (CMC) studies; laboratory sample processing, preparation, and analysis for research and clinical trial purposes; laboratory services for the collection, processing, storage, and management of biological specimens for research purposes; biorepository and biobank services, namely, storage of biological samples for scientific research; scientific laboratory services for biomarker identification, gene expression profiling, genotyping, and sequencing; and scientific consulting relating to laboratory testing and analysis in the fields of pharmaceuticals, biotechnology, and clinical research; Software as a service (SaaS) services featuring software for managing, collecting, tracking, and analyzing data in the fields of laboratory testing, diagnostic testing, and clinical trials; providing temporary use of non-downloadable software for managing clinical trial operations, namely, software for tracking clinical trial participants, recording clinical trial data, monitoring clinical trial progress, and managing clinical trial protocols; providing temporary use of non-downloadable software for collecting, processing, and analyzing medical and diagnostic information; providing temporary use of non-downloadable software for monitoring clinical trial subjects and tracking subject compliance with clinical trial protocols; providing temporary use of non-downloadable software for managing laboratory information, laboratory test results, and diagnostic testing data; providing temporary use of non-downloadable software for tracking, storing, and analyzing medical information related to clinical trial participants and laboratory test results; providing temporary use of non-downloadable software for providing information in the fields of laboratory testing, clinical testing, medical testing, diagnostic testing, and genetic testing | ACTIVE | — |
| 044 | Medical laboratory services; clinical diagnostic laboratory testing services; medical diagnostic testing services for the diagnosis, monitoring, and treatment of disease and medical conditions; diagnostic testing of biological samples for medical purposes; laboratory testing services for medical diagnostic purposes; genetic testing for medical purposes; molecular diagnostic testing services for medical purposes; biomarker testing for medical diagnostic and prognostic purposes; diagnostic testing services involving the analysis of blood, urine, tissue, saliva, and other biological specimens for medical purposes; pathology and clinical pathology laboratory services; microbiology, virology, immunology, hematology, and clinical chemistry testing services for medical diagnostic purposes; pharmacogenetic and pharmacogenomic testing for medical purposes; infectious disease testing services for medical purposes; cancer diagnostic testing services; medical testing services for detecting genetic conditions, inherited disorders, and disease susceptibility; providing medical information relating to laboratory testing, diagnostic testing, clinical testing, and genetic testing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Laboratory Corporation of America Holdings
- Other trademarks owned by Laboratory Corporation of America Holdings
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LABCORP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 6, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 6, 2026 | NWAP | NEW APPLICATION ENTERED | — |